These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11959567)

  • 1. Pharmacodynamic activity and efficacy of linezolid in a rat model of pneumococcal pneumonia.
    Gentry-Nielsen MJ; Olsen KM; Preheim LC
    Antimicrob Agents Chemother; 2002 May; 46(5):1345-51. PubMed ID: 11959567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo pharmacodynamics of a new oxazolidinone (linezolid).
    Andes D; van Ogtrop ML; Peng J; Craig WA
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3484-9. PubMed ID: 12384354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and efficacy of linezolid in a gerbil model of Streptococcus pneumoniae-induced acute otitis media.
    Humphrey WR; Shattuck MH; Zielinski RJ; Kuo MS; Biermacher JJ; Smith DP; Jensen JL; Schaadt RD; Zurenko GE; Richards IM
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1355-63. PubMed ID: 12654670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ethanol on fluoroquinolone efficacy in a rat model of pneumococcal pneumonia.
    Olsen KM; Gentry-Nielsen M; Yue M; Snitily MU; Preheim LC
    Antimicrob Agents Chemother; 2006 Jan; 50(1):210-9. PubMed ID: 16377688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of tedizolid phosphate (TR-701) in murine models of infection with penicillin-resistant and penicillin-sensitive Streptococcus pneumoniae.
    Choi S; Im W; Bartizal K
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4713-7. PubMed ID: 22713339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457.
    Hilliard JJ; Fernandez J; Melton J; Macielag MJ; Goldschmidt R; Bush K; Abbanat D
    Antimicrob Agents Chemother; 2009 May; 53(5):2028-33. PubMed ID: 19273686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cirrhosis on antibiotic efficacy in a rat model of pneumococcal pneumonia.
    Preheim LC; Olsen KM; Yue M; Snitily MU; Gentry-Nielsen MJ
    Diagn Microbiol Infect Dis; 2005 Feb; 51(2):103-11. PubMed ID: 15698715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of linezolid in experimental otitis media.
    Pelton SI; Figueira M; Albut R; Stalker D
    Antimicrob Agents Chemother; 2000 Mar; 44(3):654-7. PubMed ID: 10681334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid versus ceftriaxone/cefpodoxime in patients hospitalized for the treatment of Streptococcus pneumoniae pneumonia.
    San Pedro GS; Cammarata SK; Oliphant TH; Todisco T;
    Scand J Infect Dis; 2002; 34(10):720-8. PubMed ID: 12477321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia.
    Tessier PR; Kim MK; Zhou W; Xuan D; Li C; Ye M; Nightingale CH; Nicolau DP
    Antimicrob Agents Chemother; 2002 May; 46(5):1425-34. PubMed ID: 11959578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumonia.
    Wang E; Simard M; Bergeron Y; Beauchamp D; Bergeron MG
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1010-8. PubMed ID: 10722505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linezolid decreases susceptibility to secondary bacterial pneumonia postinfluenza infection in mice through its effects on IFN-γ.
    Breslow-Deckman JM; Mattingly CM; Birket SE; Hoskins SN; Ho TN; Garvy BA; Feola DJ
    J Immunol; 2013 Aug; 191(4):1792-9. PubMed ID: 23833238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developments in the pharmacokinetic/pharmacodynamic index of linezolid: a step toward dose optimization using Monte Carlo simulation in critically ill patients.
    Dong H; Xie J; Chen L; Wang T; Sun J; Zhao Y; Dong Y
    Int J Infect Dis; 2014 May; 22():35-40. PubMed ID: 24603161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic options for pneumococcal pneumonia in Turkey.
    Oncu S; Erdem H; Pahsa A
    Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetic/pharmacodynamic profile of linezolid in severely ill intensive care unit patients.
    Dong H; Wang X; Dong Y; Lei J; Li H; You H; Wang M; Xing J; Sun J; Zhu H
    Int J Antimicrob Agents; 2011 Oct; 38(4):296-300. PubMed ID: 21741222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of liposome-encapsulated ciprofloxacin compared with ciprofloxacin and ceftriaxone in a rat model of pneumococcal pneumonia.
    Ellbogen MH; Olsen KM; Gentry-Nielsen MJ; Preheim LC
    J Antimicrob Chemother; 2003 Jan; 51(1):83-91. PubMed ID: 12493791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation.
    Cojutti P; Maximova N; Crichiutti G; Isola M; Pea F
    J Antimicrob Chemother; 2015 Jan; 70(1):198-206. PubMed ID: 25182066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
    Moine P; Vallée E; Azoulay-Dupuis E; Bourget P; Bédos JP; Bauchet J; Pocidalo JJ
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1953-8. PubMed ID: 7811003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid against penicillin-sensitive and -resistant pneumococci in the rabbit meningitis model.
    Cottagnoud P; Gerber CM; Acosta F; Cottagnoud M; Neftel K; Täuber MG
    J Antimicrob Chemother; 2000 Dec; 46(6):981-5. PubMed ID: 11102418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid: a review of its use in the management of serious gram-positive infections.
    Perry CM; Jarvis B
    Drugs; 2001; 61(4):525-51. PubMed ID: 11324682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.